VDR and neoplasm: The relationship between vitamin D status and clinical outcomes in HNCs is complex and influenced by multiple factors, including genetic variability in vitamin D receptor (VDR) expression, tumor heterogeneity, and patient-specific metabolic differences, all these serving as weak points in clinical studies [42,43].